Home
>
National Drug Code (NDC)
>
CounterAct
CounterAct - 54473-166-30 - (Loratadine)
Drug Information of CounterAct
| Product NDC: | 54473-166 |
| Proprietary Name: | CounterAct |
| Non Proprietary Name: | Loratadine |
| Active Ingredient(s): | 10 mg/1 & nbsp; Loratadine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of CounterAct
| Product NDC: | 54473-166 |
| Labeler Name: | Melaleuca, Inc. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | ANDA075209 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20080628 |
Package Information of CounterAct
| Package NDC: | 54473-166-30 |
| Package Description: | 3 BLISTER PACK in 1 CARTON (54473-166-30) > 10 TABLET in 1 BLISTER PACK |
NDC Information of CounterAct
| NDC Code | 54473-166-30 |
| Proprietary Name | CounterAct |
| Package Description | 3 BLISTER PACK in 1 CARTON (54473-166-30) > 10 TABLET in 1 BLISTER PACK |
| Product NDC | 54473-166 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Loratadine |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20080628 |
| Marketing Category Name | ANDA |
| Labeler Name | Melaleuca, Inc. |
| Substance Name | LORATADINE |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |
